2025-03-13
Carnegie – Healthcare Day
CEO Magnus Corfitzen presents at Carnegie Company Day.
Presentations & Articles
2025-02-07
HC Andersen – Full year and Q4 2024 report with Julie Waras Brogren
HC Andersen - Q3 2024 report with Julie Waras Brogren
2025-01-29
Redeye Fight Cancer Event – January 22nd, 2025
Magnus Corfitzen, CEO at Ascelia Pharma AB presented at Redeye Fight Cancer Event
2025-01-29
HC Andersen – Julie Waras Brogren
HC Andersen - Q3 2024 report with Julie Waras Brogren
2024-11-13
HC Andersen – Q3 2024 report with Julie Waras Brogren
HC Andersen - Q3 2024 report with Julie Waras Brogren
2024-09-10
HC Andersen – Q&A with Magnus Corfitzen
Magnus Corfitzen, CEO presents at HC Andersen - Final outcome of Rights issue
2024-08-30
Carnegie – Company Day
CEO Magnus Corfitzen presents at Carnegie Company Day.
2024-08-22
Carnegie – Interview
CEO Magnus Corfitzen presents at Carnegie sharing insights on strong phase 3 results, rationale for the Rights issue 2024 and key milestones ahead
2024-08-22
Interview with Redeye
Magnus Corfitzen, CEO at Ascelia Pharma AB shared his insights on the timeline for the NDA submission of Orviglance and the ongoing Rights Issue.
2024-08-22
HC Andersen – Update on Q2 2024 and Rights issue
Julie Waras Brogren, Deputy CEO presents at HC Andersen
2024-08-13
HC Andersen Podcast – Business update
Magnus Corfitzen, CEOpresent at the HC Andersen Podcast
2024-06-17
Ascelia Pharma – Commercial and partnership strategy
Julie Waras Brogren, Deputy CEO presents at HC Andersen
2024-06-12
Interview with Redeye: commercial update and progress after successful Sparkle results
Deputy CEO Julie Waras Brogren presents at Redeye
2024-06-04
HC Andersen – Life Science Seminar
Magnus Corfitzen, CEO presents at the Life Science Seminar
2024-05-27
Penser by Carnegie- Healthcare event
CEO Magnus Corfitzen presents at Erik Penser by Carnegie Company Day.
2024-05-23
HC Andersen – Presentation of Q1 2024 report
Julie Waras Brogren, Deputy CEO presents the quarterly report Q1 2024
2024-05-14
HC Andersen – Podcast
Magnus Corfitzen, CEO and Andreas Norlin CSO present at the HC Andersen Podcast, Ascelia Pharma strong superiority of Orviglance Phase 3 study
2024-05-07
Ascelia Pharma – Investor Update 07/05/2024
...